IPO Trending
SUNRESTSME / NSEListed

Sunrest Lifescience Limited

Incorporated in 2017, Sunrest Lifescience Limited offers a wide range of healthcare and personal care products, including capsules, tablets, syrup, ointment, gel, mouthwash, solution, suspension, dry powders, and toothpaste. Its portfolio covers medicines across multiple therapeutic categories like anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-protozoal, anti-histamine, anti-hypertensive, cosmetics, anti-parasitic, multivitamin, multimineral, nutraceutical, and anti-inflammatory. With 18 registered trademarks covering 32 products, Sunrest Lifescience is focused on delivering high-quality and effective formulations to its customers.

₹84 - ₹8447.51x sub
Listed Price84.00
Listing Gain+0.00%
Review-Analyst Consensus Verdict

May apply

No review summary is available yet.

Apply
00%
May Apply
00%
Neutral
00%
Avoid
00%
Not Rated
00%
No IPO review records are available for this issue yet.